Shelter Pharma Key Ratios
BSE: 543963
₹33.00
₹1.50
(4.76%)
As on 01-Sep-2026IST
Market cap
₹56 Cr
Revenue (TTM)
₹51 Cr
P/E Ratio
6.2
P/B Ratio
0.9
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 26.58 | 19.01 | 11.00 |
| EBIT | -- | -- | 14.69 | 56.25 | 145.25 |
| Net Profit | -- | -- | 16.73 | 57.94 | 146.02 |
| EPS | -- | -- | 16.73 | 38.20 | 124.19 |
| Book Value | -- | -- | 19.80 | 51.89 | 34.57 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-25 | Mar-24 | Mar-23 |
| EBIT-Margin
| 20.84 | 14.28 | 19.33 | 21.34 | 21.86 |
| Net Margin
| 14.72 | 10.09 | 14.28 | 15.49 | 14.40 |
| Return on equity
| 30.89 | 23.86 | 18.88 | 25.58 | 48.22 |
| Return on Capital
| 39.43 | 31.15 | 25.07 | 33.62 | 59.61 |
| Return on Assets
| 22.08 | 16.52 | 16.14 | 19.74 | 30.37 |
| Debt to Equity (x)
| -- | -- | 0.03 | 0.02 | 0.13 |
Profitability
ROCE
25.07
Higher than Peers by 8.61
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Shelter Pharma
|
25.07
|
33.62
|
59.61
|
36.17
|
1.29
|
|
Peer Median
|
16.46
|
15.49
|
17.37
|
17.62
|
--
|
ROE
18.88
Higher than Peers by 5.01
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Shelter Pharma
|
18.88
|
25.58
|
48.22
|
25.95
|
0.68
|
|
Peer Median
|
13.87
|
14.72
|
15.70
|
18.36
|
--
|
ROA
16.14
Higher than Peers by 8.10
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Shelter Pharma
|
16.14
|
19.74
|
30.37
|
15.94
|
0.40
|
|
Peer Median
|
8.04
|
7.19
|
9.43
|
9.43
|
--
|
EBIT Margin
19.33
Higher than Peers by 9.29
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Shelter Pharma
|
19.33
|
21.34
|
21.86
|
8.54
|
0.33
|
|
Peer Median
|
10.05
|
10.28
|
13.90
|
17.27
|
--
|
Net Margin
14.28
Higher than Peers by 5.17
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Shelter Pharma
|
14.28
|
15.49
|
14.40
|
6.11
|
0.18
|
|
Peer Median
|
9.11
|
6.78
|
10.91
|
12.99
|
--
|
Cash Profit Margin
14.82
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Shelter Pharma
|
14.82
|
16.11
|
14.85
|
6.67
|
0.70
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
26.58
Higher than Peers by 19.41
Year on year growth in net sales
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Shelter Pharma
|
26.58
|
10.71
|
20.29
|
33.68
|
-25.22
|
|
Peer Median
|
7.17
|
10.56
|
12.63
|
15.47
|
--
|
EBIT Growth
14.69
Higher than Peers by 2.64
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Shelter Pharma
|
14.69
|
8.06
|
207.80
|
3,332.62
|
-32.25
|
|
Peer Median
|
12.05
|
6.17
|
-2.90
|
51.73
|
--
|
Net Profit Growth
16.73
Lower than Peers by 5.42
Year on year growth in profit after tax
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Shelter Pharma
|
16.73
|
19.10
|
183.39
|
4,358.74
|
-48.69
|
|
Peer Median
|
22.15
|
27.97
|
-14.10
|
44.15
|
--
|
EPS Growth
16.73
Higher than Peers by 7.92
Year on year growth in earnings per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Shelter Pharma
|
16.73
|
-20.21
|
183.39
|
4,358.74
|
-51.87
|
|
Peer Median
|
8.80
|
--
|
-3.68
|
38.52
|
--
|
Book Value Growth
19.80
--
Year on year growth in book value per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Shelter Pharma
|
19.80
|
156.29
|
70.37
|
29.45
|
3.72
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.03
Lower than Peers by 0.01
Total debt / Net worth
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Shelter Pharma
|
0.03
|
0.02
|
0.13
|
0.02
|
0.00
|
|
Peer Median
|
0.03
|
0.05
|
0.14
|
0.23
|
--
|
Short term debt to equity ratio
0.00
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Shelter Pharma
|
0.00
|
0.00
|
0.09
|
0.00
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
7.19
Higher than Peers by 4.99
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Shelter Pharma
|
7.19
|
6.67
|
3.00
|
2.65
|
2.71
|
|
Peer Median
|
2.20
|
1.93
|
1.82
|
1.75
|
--
|
Quick Ratio
4.40
Higher than Peers by 2.69
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Shelter Pharma
|
4.40
|
4.68
|
1.72
|
1.12
|
1.33
|
|
Peer Median
|
1.72
|
1.59
|
1.30
|
1.04
|
--
|
Interest Coverage
72.95
Higher than Peers by 60.67
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Shelter Pharma
|
72.95
|
32.42
|
278.06
|
32.60
|
4.62
|
|
Peer Median
|
12.28
|
12.45
|
16.98
|
15.07
|
--
|
Operating Efficiency
Debtors to sales
18.70
Lower than Peers by 7.53
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Shelter Pharma
|
18.70
|
22.11
|
22.67
|
5.34
|
3.38
|
|
Peer Median
|
26.23
|
23.97
|
24.57
|
20.26
|
--
|
Asset Turnover
1.13
Higher than Peers by 0.39
Sales / Average Total Assets
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Shelter Pharma
|
1.13
|
1.27
|
2.11
|
2.61
|
2.16
|
|
Peer Median
|
0.74
|
0.88
|
0.82
|
0.79
|
--
|
Receivable days
66.01
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Shelter Pharma
|
66.01
|
77.72
|
49.47
|
14.36
|
11.15
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
82.22
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Shelter Pharma
|
82.22
|
81.59
|
68.85
|
58.83
|
67.55
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
9.68
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Shelter Pharma
|
9.68
|
7.45
|
5.49
|
4.48
|
4.93
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
138.55
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Shelter Pharma
|
138.55
|
151.86
|
112.83
|
68.72
|
73.77
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
5.78
Lower than Peers by 33.39
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Shelter Pharma
|
5.78
|
9.17
|
--
|
--
|
--
|
|
Peer Median
|
39.17
|
40.74
|
25.97
|
33.71
|
--
|
Price / Book Value
1.00
Lower than Peers by 2.61
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Shelter Pharma
|
1.00
|
1.63
|
--
|
--
|
--
|
|
Peer Median
|
3.61
|
3.87
|
2.79
|
4.36
|
--
|
Dividend Yield
0.97
Higher than Peers by 0.78
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Shelter Pharma
|
0.97
|
0.67
|
--
|
--
|
--
|
|
Peer Median
|
0.19
|
0.20
|
0.65
|
0.28
|
--
|
EV/EBITDA
3.92
Lower than Peers by 24.88
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Shelter Pharma
|
3.92
|
5.96
|
1.13
|
0.19
|
0.60
|
|
Peer Median
|
28.79
|
25.41
|
15.07
|
23.32
|
--
|
Market Cap
42
Lower than Peers by 3,903
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Shelter Pharma
|
42
|
57
|
--
|
--
|
--
|
|
Peer Median
|
3,944
|
2,959
|
3,742
|
6,050
|
--
|
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
